(1 year, 7 months ago)
Commons ChamberIt is a delight to see the right hon. Lady in her new position. As a previous member of the Select Committee on Science and Technology, at least she will know something about science.
I would like to believe the story that is being told about this country being a life sciences superpower, but I am sure the right hon. Lady will have noted the comments in January of Kate Bingham, the chair of the vaccine taskforce. She said that the lessons from that taskforce had not been learned, and that this country was falling behind. She gave evidence of AstraZeneca and GlaxoSmithKline investing outside this country because civil servants had not learned those lessons and had created a hostile environment for such companies.
I can understand that point, and I take this opportunity to pay tribute to Kate Bingham for her past work on the vaccine taskforce. We have created the new Department for Science, Innovation and Technology so that we can drive forward science, and life sciences as part of that, as a force for good. More on this agenda will be set out in the coming weeks, because we have the opportunity to continue to ensure the UK’s leadership on it. That is my priority and that of all of my team.